Last reviewed · How we verify

Adductor Canal Block with Morphine

University Health Network, Toronto · FDA-approved active Small molecule

Morphine delivered via adductor canal block provides regional anesthesia and analgesia by blocking nerve conduction in the femoral nerve and its branches while achieving high local drug concentrations.

Morphine delivered via adductor canal block provides regional anesthesia and analgesia by blocking nerve conduction in the femoral nerve and its branches while achieving high local drug concentrations. Used for Postoperative analgesia following knee surgery, Postoperative analgesia following lower extremity surgery.

At a glance

Generic nameAdductor Canal Block with Morphine
Also known asropivacaine with epinephrine and spinal intrathecal morphine
SponsorUniversity Health Network, Toronto
Drug classRegional anesthetic with opioid adjuvant
TargetPeripheral opioid receptors (mu-opioid receptor)
ModalitySmall molecule
Therapeutic areaAnesthesia and Pain Management
PhaseFDA-approved

Mechanism of action

The adductor canal block is a regional anesthesia technique that targets the saphenous nerve and other branches of the femoral nerve in the adductor canal region of the thigh. When morphine is added to the local anesthetic solution, it enhances and prolongs analgesia through opioid receptor activation at peripheral nerve terminals and spinal cord levels, reducing postoperative pain without the systemic side effects of intravenous opioids.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: